How is it that the person in charge has no clue ab
Post# of 148170
Fauci knows about leronlimab more than we do. So only two answers are possible. One--because he doesn't want to mention any names before a drug has proved itself in the trial. Two--Fauci is a lead agent of the biotech-medical research complex--similar to the military-industrial complex--and was planted in the WH to defend its interests. Leronlimab is a nightmare come true for these interests and the least Fauci can do for his friends is keep the L word off the public discourse on Covid-19.
We'll learn which of these two answers is right when we are done with our mild to moderate trial. Similarly, the FDA decision on our request for compassionate use will be a litmus test of their number.
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.